Home / The Science Behind It

THE SCIENCE BEHIND IT

It used to be that we’d only take a probiotic if we just finished a round of antibiotics or were prone to conditions like yeast infections. We’ve come a long way. Studies now show that probiotics can prevent, ease, or eliminate symptoms of at least 22 chronic conditions especially when taken along with a healthy diet, exercise, and lifestyle. 

Immune System 

Nervous System

Digestive System

  1. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial.
  2. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
  3. Efficacy of Bacillus coagulans strain Unique IS-2 in the treatment of patients with acute diarrhea.
  4. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. 
  5. Original Research: Bacillus coagulans Significantly Improved Abdominal Pain and Bloating in Patients with IBS.
  6. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
  7. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. 
  8. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
  9. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 
  10. Effects of dietary fiber with Bacillus coagulans lilac-01 on bowel movement and fecal properties of healthy volunteers with a tendency for constipation. 
  11. Effect of Spore-bearing Lactic Acid-forming Bacteria ( Bacillus coagulans SANK 70258) Administration on the Intestinal Environment, Defecation Frequency, Fecal Characteristics and Dermal Characteristics in Humans and Rats. 
  12. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. 
  13. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
  14. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. 
  15.  Dose–Response Efficacy of a Proprietary Probiotic Formula ofLactobacillus acidophilusCL1285 andLactobacillus caseiLBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients.
  16. Efficacy of BIO K+ CL1285® in the reduction of antibiotic-associated diarrhea–a placebo controlled double-blind randomized, multi-center study. 
  17. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
  18. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo controlled clinical trial.
  19. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. 
  20. Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? 
  21. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. 
  22. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. 
  23. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.
  24. Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans. 
  25. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. 
  26. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. 
  27. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. 
  28. Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.  
  29. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. 

Healthy Body Weight

YOU MIGHT ALSO BE INTERESTED IN

Initial Consultation
$0.00